Get the app
USHealthcare

P3 Health Partners Inc (PIII)

US · Healthcare · Medical Care Facilities

$7.88+3.55%
Last close · 2026-09-17

Latest quarter · ended 2026-06-30

Revenue
$386.4M
Revenue YoY
+8.6%
Net profit
$7.4M
EPS
$-0.63
EPS estimate
$-1.89
Net margin
1.9%

EPS came in at -0.63 against a street estimate of -1.89 — a beat of 66.7%.

Key statistics

Market cap
$1.55B
Forward P/E
0.0
P/B
0.62
Book value
$-23.59
EPS (TTM)
$-33.01
52-week high
$16.89
52-week low
$1.52
50-day MA
$10.06
200-day MA
$6.34
Beta
1.62

Analyst view

Analysts rate P3 Health Partners Inc a buy (2 buy, 2 hold, 0 sell out of 4) with an average price target of $18.00.

Shareholding

Insiders
48.38%
Institutions
8.24%

Largest institutional holders

FundStake
Vanguard Capital Management, LLC1.81%
Geode Capital Management, LLC0.66%
CI Private Wealth LLC0.50%
Nine Masts Capital Limited0.46%
Abundance Wealth Counselors0.41%
HRT FINANCIAL LLC0.39%
Diversified Trust Co0.34%
Susquehanna International Group, LLP0.34%

Recent filings & reports

DocumentDate
Material agreement · Q3 2026
P3 HEALTH PARTNERS INC. (PIII) – FORM 8-K SUMMARY HEADLINE NUMBERS • Company secured up to $70 million in funding through Securities Purchase Agreem
2026-09-11
Quarterly report · Q2 2026
P3 HEALTH PARTNERS INC. — Q2 2026 FORM 10-Q SUMMARY --- HEADLINE NUMBERS • Total assets: $654.4 million (June 30, 2026) vs. $656.6 million (Decembe
2026-08-10
Results announced · Q3 2026
P3 HEALTH PARTNERS INC. – Q2 2026 RESULTS SUMMARY --- HEADLINE NUMBERS • Q2 2026 At-Risk Members: 105,000 (down 10% year-over-year due to intention
2026-08-10
Material agreement · Q2 2026
P3 HEALTH PARTNERS INC. - FORM 8-K SUMMARY HEADLINE NUMBERS • Debt Maturity Extension: Repurchase Promissory Note maturity date extended to Septembe
2026-07-06
Shareholder vote results · Q2 2026
P3 HEALTH PARTNERS INC. - FORM 8-K SUMMARY HEADLINE NUMBERS • Annual Meeting of Stockholders held June 9, 2026 • Company trades on NASDAQ under symb
2026-06-10
Current report · Q2 2026
P3 HEALTH PARTNERS INC. - DOCUMENT SUMMARY HEADLINE NUMBERS • Company: P3 Health Partners Inc. (Nasdaq ticker: PIII) • Headquarters: 2370 Corporate
2026-05-26
Quarterly report · Q1 2026
P3 HEALTH PARTNERS INC. — Q1 2026 FORM 10-Q SUMMARY HEADLINE NUMBERS • Q1 2026 total operating revenue: $386.4 million (up from $373.2 million in Q1
2026-05-14
Proxy statement · Q2 2026
P3 HEALTH PARTNERS INC. — PROXY STATEMENT SUMMARY CEO COMPENSATION • Aric Coffman, M.D. (CEO) total 2025 compensation: Not specified in provided doc
2026-04-30

Readable in the app.

Corporate actions

ActionDetailDate
Split1 : 50
effective Apr 14, 2025
2025-04-14

Deals & corporate news

AnnouncementDate
Won multi-year Medicare Advantage support contract with Nebraska health insurance provider
P3 Health Partners signed a new contract with a major Nebraska-based nonprofit health insurance provider, effective March 19, 2026. Under this deal, P3 will provide clinical, operational, an
2026-03-25
Formation of joint venture MSO with Commonwealth Primary Care ACO
P3 Health Partners formed a joint management company called P3 Commonwealth Innovation MSO with Commonwealth Primary Care ACO on November 11, 2025. The MSO will handle administrative and ope
2025-11-14

See the full picture

Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for P3 Health Partners Inc — free to start.

Google PlayApp Store

Other Healthcare companies

Data updated 2026-09-18.